Anita Y. Chhabra
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A pathway toward clinical translation of hyperpolarized [1,4-13C2,2,3-d2]fumarate as an imaging biomarker for early cellular necrosis in vivo.
Journal: Magnetic resonance in medicine
Published: October 15, 2024
The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer.
Journal: Nature
Published: February 06, 2024
Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-13C]Pyruvate Demonstrates Heterogeneity in Lactate Labeling: A Proof of Principle Study.
Journal: Radiology. Imaging cancer
Published: July 15, 2022
Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol.
Journal: BMJ open
Published: November 25, 2020
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.
Journal: Health technology assessment (Winchester, England)
Published: September 04, 2020
Imaging breast cancer using hyperpolarized carbon-13 MRI.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 23, 2020
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Journal: Lancet (London, England)
Published: December 13, 2018
Facilitating cells: role in inducing transplantation tolerance.
Journal: Current opinion in organ transplantation
Published: July 20, 2018
HSCT-Based Approaches for Tolerance Induction in Renal Transplant.
Journal: Transplantation
Published: June 03, 2017
Last Updated: 09/26/2026